Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs2981582
rs2981582
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE In the haplotype analysis, the FGFR2 rs2981582 T / rs2420946 T / rs1219648 G haplotype (ht2) was associated with a significantly increased BC risk compared with the rs2981582 C / rs2420946 C / rs1219648 A haplotype in familial BC and in non-familial early-onset BC (OR = 1.32, 95 % CI 1.06-1.65, P = 0.012; OR = 1.46, 95 % CI 1.11-1.91, P = 0.004, respectively). 23225170 2013
dbSNP: rs1219648
rs1219648
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE Only 5 out of 9 GWAS breast cancer loci were found to be significantly associated with breast cancer in Tunisians: The rs1219648 (G vs. A allele: OR = 1.36, P = 1 × 10(-3)) and rs2981582 (A vs. G allele: OR = 1.55, P = 3 × 10(-6)) of FGFR2 gene; the rs8051542 of the TNRC9 gene (T vs. C allele: OR = 1.40, P = 4 × 10(-4)); the rs889312 of the MAP3K1 gene (C vs. A allele: OR = 1.33, P = 3 × 10(-3)) and the rs13281615 located on 8q24 (G vs. A allele: OR = 1.21, P = 0.03). 22910930 2012
dbSNP: rs1219648
rs1219648
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE Four SNPs mapped to 10q26.13/FGFR2 were associated with increased breast cancer risk via an additive model with per-allelic risks (95 % CI) of 1.26 (1.12-1.43) at rs1219648, 1.22 (1.07-1.38) at rs2981582, 1.21 (1.07-1.36) at rs2981579, and 1.18 (1.04-1.35) at rs11200014. 22965832 2012
dbSNP: rs1219648
rs1219648
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE To examine whether these variants contribute to risk of radiation-associated breast cancer in HL, we analyzed 2 independent case-control series, from the United Kingdom and The Netherlands, totaling 693 HL patients, 232 with breast cancer and 461 without. rs1219648, which annotates the FGFR2 gene, was associated with risk in both series (combined per-allele odds ratio = 1.59, 95% confidence interval: 1.26-2.02; P = .000111). 22144180 2012
dbSNP: rs2981582
rs2981582
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE Overall, all of the five SNPs contributed to breast cancer susceptibility in a dominant genetic model (2q35, rs13387042: adjusted OR = 1.26, P = 0.006; 3q24.1, rs2307032: adjusted OR = 1.24, P = 0.005; 6q22.33, rs2180341: adjusted OR = 1.22, P = 0.006; 6q25.1, rs2046210: adjusted OR = 1.51, P = 2.40 × 10-8; 10q26.13, rs2981582: adjusted OR = 1.31, P = 1.96 × 10-4). 22269215 2012
dbSNP: rs2981582
rs2981582
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE Four SNPs mapped to 10q26.13/FGFR2 were associated with increased breast cancer risk via an additive model with per-allelic risks (95 % CI) of 1.26 (1.12-1.43) at rs1219648, 1.22 (1.07-1.38) at rs2981582, 1.21 (1.07-1.36) at rs2981579, and 1.18 (1.04-1.35) at rs11200014. 22965832 2012
dbSNP: rs2981582
rs2981582
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE In attempt to investigate whether FGFR2 polymorphisms are associated with a risk of breast cancer in Chinese women of the Han nationality, we genotyped single-nucleotide polymorphisms (SNPs) of seven FGFR2 sites (rs2981582, rs17102287, rs17542768, rs10510097, rs11200012, rs3750817, rs2981578) in 816 women including 388 breast cancer patients and 428 healthy controls via the polymerase chain reaction single-strand conformation polymorphism procedure as well as sequence detection. 21822685 2012
dbSNP: rs2981582
rs2981582
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE Only 5 out of 9 GWAS breast cancer loci were found to be significantly associated with breast cancer in Tunisians: The rs1219648 (G vs. A allele: OR = 1.36, P = 1 × 10(-3)) and rs2981582 (A vs. G allele: OR = 1.55, P = 3 × 10(-6)) of FGFR2 gene; the rs8051542 of the TNRC9 gene (T vs. C allele: OR = 1.40, P = 4 × 10(-4)); the rs889312 of the MAP3K1 gene (C vs. A allele: OR = 1.33, P = 3 × 10(-3)) and the rs13281615 located on 8q24 (G vs. A allele: OR = 1.21, P = 0.03). 22910930 2012
dbSNP: rs2981582
rs2981582
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), rs3817198 (LSP1), rs889312 (MAP3K1), rs3803662 (TOX3), rs13387042 (2q35), rs4973768 (SLC4A7), rs6504950 (COX11) and rs10941679 (5p12) were genotyped for 25 853 BC patients with the available follow-up; 62 other SNPs, which have been suggested as BC risk SNPs by a GWAS or as candidate SNPs from individual studies, were genotyped for replication purposes in subsets of these patients. 22532573 2012
dbSNP: rs1219648
rs1219648
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation GWASDB Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. 21263130 2011
dbSNP: rs1219648
rs1219648
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
G 0.800 GeneticVariation GWASDB A combined analysis of genome-wide association studies in breast cancer. 20872241 2011
dbSNP: rs1219648
rs1219648
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE The FGFR2-breast cancer association was modified by smoking status, with increased risk for former and current smokers compared to never smokers; former/current smokers carrying two copies of the rs1219648 minor allele were at highest risk with a crude OR (95% confidence interval) of 2.11 (1.52-2.92) compared to never smokers with no rs1219648 variant alleles. 20853316 2011
dbSNP: rs1219648
rs1219648
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE Therefore, the SNPs of TGFB1 rs1982073 and FGFR2 rs1219648 may contribute to the identification of patients with more aggressive breast cancers among Han women in North China. 20640597 2011
dbSNP: rs2981582
rs2981582
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE SNPs rs2981582 and rs2981578, located in a linkage disequilibrium block (LD block) within intron 2 of the fibroblast growth factor receptor 2 gene (FGFR2), are associated with a mildly increased breast cancer risk. 21767389 2011
dbSNP: rs1219648
rs1219648
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE Three commonly studied FGFR2 polymorphisms including rs1219648 (A > G), rs2420946 (C > T), and rs2981582 (C > T) were selected to explore their association with risk of development of breast cancer by meta-analysis of published case-control studies. 20300826 2010
dbSNP: rs1219648
rs1219648
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE In conclusion, this meta-analysis suggests that rs2981582, rs1219648, and rs2420946 polymorphisms in FGFR2 are associated with elevated BC risk. 20364400 2010
dbSNP: rs2981582
rs2981582
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE We conducted a literature review to identify case-control studies of variants in 4 genes known to affect breast cancer risk: CHEK2*1100delC; multiple variants in BRCA1 and BRCA2; and FGFR2 rs2981582. 20299982 2010
dbSNP: rs2981582
rs2981582
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE Odds ratios for breast cancer were greatest for FGFR2-rs2981582 and TNRC9-rs3803662 and, for these 2 SNPs, were significantly greater for estrogen receptor (ER)-positive than for ER-negative disease, both in our data and in meta-analyses of all published data (pooled per-allele ORs [95% confidence intervals] for ER-positive vs ER-negative disease: 1.30 [1.26-1.33] vs 1.05 [1.01-1.10] for FGFR2; interaction P < .001; and 1.24 [1.21-1.28] vs 1.12 [1.07-1.17] for TNRC9; interaction P < .001). 20664043 2010
dbSNP: rs2981582
rs2981582
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE We tested gene-environment interactions in 7610 women who developed breast cancer and 10 196 controls without the disease, studying the effects of 12 polymorphisms (FGFR2-rs2981582, TNRC9-rs3803662, 2q35-rs13387042, MAP3K1-rs889312, 8q24-rs13281615, 2p-rs4666451, 5p12-rs981782, CASP8-rs1045485, LSP1-rs3817198, 5q-rs30099, TGFB1-rs1982073, and ATM-rs1800054) in relation to prospectively collected information about ten established environmental risk factors (age at menarche, parity, age at first birth, breastfeeding, menopausal status, age at menopause, use of hormone replacement therapy, body-mass index, height, and alcohol consumption). 20605201 2010
dbSNP: rs2981582
rs2981582
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE Overall, significantly elevated BC risk was associated with rs2981582, rs1219648, and rs2420946 risk allele when all studies were pooled into the meta-analysis. 20364400 2010
dbSNP: rs2981582
rs2981582
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE Three commonly studied FGFR2 polymorphisms including rs1219648 (A > G), rs2420946 (C > T), and rs2981582 (C > T) were selected to explore their association with risk of development of breast cancer by meta-analysis of published case-control studies. 20300826 2010
dbSNP: rs2981582
rs2981582
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE In the context of a nationwide, population-based case-control study in Sweden, we retrieved recorded birth weight for 693 breast cancer cases and 747 control women who were also genotyped for most or all of the seven recently documented breast cancer susceptibility SNPs: rs2981582, rs12443621, rs8051542, rs3803662, rs889312, rs13281615, and rs3817198. 20054709 2010
dbSNP: rs1219648
rs1219648
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE FGFR2 rs1219648 and rs2981582 genotypes were significantly associated with breast cancer</span> in EA only in estrogen receptor-positive (ER+), progesterone receptor-positive (PR+) and HER2/Neu-negative (HER2-) tumors. 19028704 2009
dbSNP: rs1219648
rs1219648
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE Two single-nucleotide polymorphisms, rs13387042 (2q35) and rs1219648 (FGFR2 gene), were found to be associated with breast cancer risk. 19789366 2009
dbSNP: rs2981582
rs2981582
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.800 GeneticVariation BEFREE The study by Easton et al reported two FGFR2 SNPs, rs2981582 and rs7895676, to be among those most strongly associated with BC risk. 19536173 2009